Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-France urges parts review after Airbus A380 engine blowout

Wed, 30th Sep 2020 17:31

(Adds Rolls-Royce comment)

By Tim Hepher and Laurence Frost

PARIS, Sept 30 (Reuters) - French investigators have called
for a review of the design and maintenance of titanium alloy
engine parts to ensure they guard against the risks of metal
fatigue following an engine blowout on an Airbus A380
exactly three years ago.

France's BEA agency made the recommendation in a final
report into the accident in which an Air France jet carrying
more than 500 passengers lost the front section of one of its
four engines while flying over Greenland, before landing safely
in Canada.

The move follows a perilous investigation involving a
21-month international aerial and ground search across the ice
sheet to find a crucial titanium alloy fragment, buried 3 metres
below the surface and just a metre away from a hidden crevasse.

The probe focused on the fan hub at the centre of a
3-metre-wide fan at the front of the engine made by Engine
Alliance, co-owned by General Electric and Pratt &
Whitney.

The BEA said a recovered fragment had shown tiny fatigue
cracks in a titanium alloy called Ti-6-4 and urged regulators -
the Federal Aviation Administration and European Union Aviation
Safety Agency - to carry out a review of design, manufacturing,
maintenance and certification processes.

"Neither the manufacturer nor the certification authorities
had anticipated this phenomenon in this alloy during the design
of the engine," the BEA said.

Such recommendations by leading investigators do not have to
be followed automatically but typically carry some weight.

Engine Alliance said it had already taken steps to address
the findings. Airbus said no flaws had been found during
inspections of other engines from the same supplier, one of two
A380 engine manufacturers alongside Rolls-Royce.

A spokeswoman for Rolls said it was confident the issues
associated with the Engine Alliance part "cannot be attributed
to any Rolls-Royce engine fan discs currently in service".

Titanium alloy is used widely in aerospace, the metal's
biggest customer due to its strength compared to the weight of
each part, and its ability to handle high temperatures.

The industry has faced concerns in the past about titanium
alloy manufacturing processes following an engine failure.

In 1989, a severe engine blowout on a United Airlines DC-10
led to the death of 111 people during an attempted landing at
Sioux City, Iowa.

That crash sped improvements in manufacturing methods for
titanium alloy. But some engine experts have rejected any
suggestion that there is an industry-wide manufacturing issue.

During the operation in Greenland to find the missing A380
engine fragment, French, Danish and U.S. specialists battled
problems from faulty generators to storms, buried tents and
concerns about polar bears, according to an expedition report.

At one point, the team resorted to low-tech methods
including bamboo sticks and concentrated juice to mark the snow
after their high-precision positioning system failed, but the
investigation also spurred development of new sensor equipment.
(Reporting by Tim Hepher and Laurence Frost; Editing by Pravin
Char)

Related Shares

More News

Sunday newspaper round-up: Pfizer, GlaxoSmithKline, Rolls-Royce

(Sharecast News) - Pfizer's most senior UK executive has criticised the call to forgo patents on Covid vaccines, warning that it would lead to a global shortage of raw materials. Ben Osborn, who leads the American drugs giant in the UK, said an intellectual-property waiver was "not the answer". "We would see a very rapid short-term impact," he said. "It could allow any organisation to start procuring some of these basic raw materials across multiple countries." Osborn, 44, said it could even mean that existing vaccine manufacturers - which include Astra Zeneca and US biotech venture Moderna - would be unable to fulfil their obligations to deliver doses. - Sunday Times

16 May 21 12:25

BROKER RATINGS: JPMorgan raises Sage to Neutral; MS ups Whitbread

BROKER RATINGS: JPMorgan raises Sage to Neutral; MS ups Whitbread

14 May 21 09:39

TOP NEWS: Rolls-Royce expects to turn cash positive in second half

TOP NEWS: Rolls-Royce expects to turn cash positive in second half

13 May 21 09:31

LONDON MARKET PRE-OPEN: Burberry brings payout back to pre-virus level

LONDON MARKET PRE-OPEN: Burberry brings payout back to pre-virus level

13 May 21 07:52

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.